Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,276,763 papers from all fields of science
Search
Sign In
Create Free Account
Caspases, Effector
Known as:
Caspases, Effector [Chemical/Ingredient]
, Effector Caspases
A subclass of caspases that contain short pro-domain regions. They are activated by the proteolytic action of INITIATOR CASPASES. Once activated they…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
In Blood
Process of secretion
aspects of radiation effects
chemical synthesis
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Programmed Cell Death, from a Cancer Perspective: An Overview
A. Mishra
,
B. Salehi
,
+4 authors
M. Nigam
Molecular Diagnosis & Therapy
2018
Corpus ID: 4042639
Programmed cell death (PCD) is probably the most widely discussed subject among the topics of cancer therapy. Over the last 2…
Expand
Highly Cited
2005
Highly Cited
2005
Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells.
B. Carter
,
M. Gronda
,
+17 authors
A. Schimmer
Blood
2005
Corpus ID: 477245
We tested the effects of small-molecule XIAP antagonists based on a polyphenylurea pharmacophore on cultured acute myelogenous…
Expand
Highly Cited
2005
Highly Cited
2005
IAPs are functionally non-equivalent and regulate effector caspases through distinct mechanisms
T. Tenev
,
A. Zachariou
,
R. Wilson
,
M. Ditzel
,
P. Meier
Nature Cell Biology
2005
Corpus ID: 8162542
Some members of the inhibitor of apoptosis (IAP) family suppress apoptosis by neutralizing caspases. The current model suggests…
Expand
2005
2005
Caspase-9 and effector caspases have sequential and distinct effects on mitochondria
E. Cepero
,
A. King
,
Lane M Coffey
,
Rebeka G Perez
,
L. Boise
Oncogene
2005
Corpus ID: 31765037
Proapoptotic Bcl-2 family members alter mitochondrial permeability resulting in the release of apoptogenic factors that initiate…
Expand
Review
2004
Review
2004
Caspases, IAPs and Smac/DIABLO: mechanisms from structural biology.
E. Shiozaki
,
Yigong Shi
TIBS -Trends in Biochemical Sciences. Regular ed
2004
Corpus ID: 21180107
Highly Cited
2003
Highly Cited
2003
Diclofenac induces apoptosis in hepatocytes by alteration of mitochondrial function and generation of ROS.
M. Gómez‐Lechón
,
X. Ponsoda
,
E. O'connor
,
T. Donato
,
J. Castell
,
R. Jover
Biochemical Pharmacology
2003
Corpus ID: 7444056
Highly Cited
2003
Highly Cited
2003
Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide.
Liling Yang
,
T. Mashima
,
+5 authors
T. Tsuruo
Cancer Research
2003
Corpus ID: 12397966
The inhibitor of apoptosis proteins (IAPs) plays a central role in repressing caspase-mediated cell death. However, little is…
Expand
Highly Cited
2000
Highly Cited
2000
Potent and Selective Nonpeptide Inhibitors of Caspases 3 and 7 Inhibit Apoptosis and Maintain Cell Functionality*
Dennis Lee
,
Scott A. Long
,
+28 authors
M. Nuttall
Journal of Biological Chemistry
2000
Corpus ID: 25468744
Caspases have been strongly implicated to play an essential role in apoptosis. A critical question regarding the role(s) of these…
Expand
Highly Cited
2000
Highly Cited
2000
The role of Apaf-1, caspase-9, and bid proteins in etoposide- or paclitaxel-induced mitochondrial events during apoptosis.
C. Perkins
,
G. Fang
,
C. N. Kim
,
K. Bhalla
Cancer Research
2000
Corpus ID: 8518307
Ectopic overexpression of Apaf-1 (2.5-fold) in human acute myelogenous leukemia HL-60 cells (HL-60/Apaf-1 cells) induced…
Expand
Review
1999
Review
1999
Apoptosis: checkpoint at the mitochondrial frontier.
E. Bossy‐Wetzel
,
D. Green
Mutation research
1999
Corpus ID: 20100738
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE